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Abstract
Background Gastric banding is thought to decrease appetite
in addition to the mechanical effects of food restriction,
although this has been difficult to demonstrate in human
studies. Our aim was to investigate the changes in
orexigenic signals in the obese Zucker rat after gastric
banding.
Methods Obese Zucker rats ( fa/fa) were submitted to
gastric banding (GBP), sham gastric banding fed ad libitum
(sham), or sham operation with food restriction, pair-fed to
the gastric banding group (sham-PF). Lean Zucker rats
( fa/+) were used as additional controls. Body weight and
food intake were daily recorded for 21 days after surgery
when epididymal fat was weighed and fasting ghrelin and
hypothalamic NPY mRNA expression were measured.
Results Gastric banding in obese Zucker rats resulted in a
significant decrease of cumulative body weight gain and
food intake. Furthermore, gastric banded rats were leaner
than Sham-PF, as expressed by a significantly lower
epididymal fat weight. Ghrelin levels of gastric banded rats
were not increased when compared to sham-operated
animals fed ad libitum and were significantly lower than
the levels of weight matched sham-PF rats (1116.9±103.3 g
GBP vs 963.2±54.3 g sham, 3,079.5±221.6 sham-PF and
2,969.9±150.9 g lean rats, p<0.001); hypothalamic NPY
mRNA expression was not increased in GBP when
compared to sham-operated rats.
Conclusion In obese Zucker rats, GBP prevents the
increase in orexigenic signals that occur during caloric
deprivation. Our data support the hypothesis that sustained
weight loss observed after gastric banding does not depend
solely on food restriction.
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Introduction
Overweight and obesity have increased exponentially all
over the world in the last few decades [1, 2]. As obesity is a
chronic disease, often, there is weight regain after weight
loss attained by most medical therapies [3, 4]. Bariatric
surgery is the most effective treatment for severe obesity, as
it allows sustained weight loss and improves most of the
comorbidities associated with the disease [5].
Several studies have now shown that bariatric surgery,
besides causing either food restriction and/or malabsorp-
tion, also induces a decrease in food intake [6–10] and
changes metabolic pathways towards increased energy
expenditure [11–13]. Moreover, there is growing evidence
that bariatric surgery is able to interfere with the systems
that regulate appetite and satiety [8–10, 14]. Gastrointesti-
nal hormones are important signals that regulate food
intake: changes in the levels of ghrelin, peptide YY
(PYY), and glucagon-like peptide 1 (GLP-1) observed after
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obesity surgery have been hypothesized to mediate the
anorexigenic effect of these surgical procedures [15].
However, results from several human studies have been
contradictory [16–19]. There is, therefore, a need to test in
animal models the hypothesis that decrease in orexigenic
signals, coming from the gastrointestinal tract and hunger
signals in the hypothalamus, mediate weight loss induced
by gastric banding.
The obese Zucker rat ( fa/fa) is the most widely used
animal model of obesity. It is also better suited to study the
effects of bariatric surgery than the normal weight Wistar
rat, as it replicates most of the features observed in the
common human obesity. The obese Zucker rat ( fa/fa) is a
spontaneous genetic model of obesity that exhibits hyper-
phagia, hyperinsulinemia, and hyperlipidemia without
severe increase in plasma glucose levels. It carries a
mutation of the gene encoding the leptin receptor that
diminishes leptin signaling resulting in leptin resistance
and consequently hyperphagia and positive energy balance
[20–22]. Although mutations of the leptin receptor in the
general human population are thought to be rare and
unlikely to contribute to a significant proportion of cases
of morbid obesity [23], for unknown reasons, leptin
resistance is commonly found in most human obese
individuals. The phenomenon is considered to be either
polygenic, multifactorial, or acquired [24–26].
After having established an animal model of gastric
banding in the normal weight Wistar rat [27, 28], our aim
now was to apply the same surgical procedure to an obese
animal and to investigate the metabolic and endocrine
changes induced by gastric banding in the obese Zucker rat.
Materials and Methods
Animals
Forty male Zucker rats (8 weeks old), 28 obese (fa/fa), and
12 lean (fa/+) purchased from a commercial breeder
(Charles River, Barcelona, Spain) were maintained in
individual cages under controlled temperature (21–23°C),
humidity, and light (12 h light, 12 h dark, lights on at
7:00 A.M.) with access to standard rat chow (A04, Panlab,
s.l., Barcelona, Spain) and tap water. Animals were
acclimatized to the local facilities for 7 days before surgery,
and only healthy growing animals were used in the
experiments. Obese Zucker rats were randomized into three
weight-matched groups to be submitted either to gastric
banding (n=9), sham gastric banding (n=8), and sham-
operated pair-fed (n=11) to the gastric banding group,
whereas all lean Zucker rats (n=12) were submitted to
sham gastric banding to be used as lean controls. All
procedures were approved by the local Ethics Board for
Animal Research and followed the European Union laws
on animal protection (86/609/EC).
Gastric Banding
After an overnight 12-h fast, rats were anaesthetized by
intraperitoneal injection of a mixture of ketamine 60 mg/kg
(Imalgene 1000, Merial) and xylazine 12 mg/kg (Rompun,
Bayer) according to body weight. Prophylactic antibiother-
apy consisting of 1.25 mg ampicillin (Cilin, Quimedical)
plus 1.25 mg flucloxacillin (Floxapen, GSK) diluted in 1 ml
of sterile water was administered intraperitoneally and
immediately before surgery. The surgical technique for
gastric banding and sham surgery was performed as
previously described for the Wistar rat [28]. Briefly, a
midline abdominal incision was made and the stomach
exposed to insert a 14-mm-long and 2-mm-wide silicon
band, custom-made, at the glandular portion of the gastric
fundus immediately below the rumen, partially restraining
the stomach volume and creating upper and lower pouches
in the stomach. To keep the band from sliding and from
dislocation, two vertical stitches (Prolene 5/0, Ethicon,
Edinburgh) were placed in the anterior view of the stomach
wall near the lesser and the greater curvatures. The
abdominal wall was closed with re-absorbable sutures
(Vycril 3/0, Ethicon).
For the sham operation, the technique consisted of the
same procedure described above except for the placing of a
non-restraining band in the same location which was
removed immediately before closure of the abdominal wall.
Both groups of animals were given 5 ml sterile warmed
saline subcutaneously to avoid dehydration and allowed to
recover spontaneously from anesthesia and surgery. Rats
were returned to their home cages which contained a
pre-weighed amount of food.
Feeding Studies Protocols
Body weight was measured daily at 9:00 A.M using a scale
(Monobloc, Metterr, Toledo, USA) recording to the nearest
1 g, and the remaining food in the hopper was reweighed at
the same time using a scale (Kern, KB 5000-1) recording to
the nearest 0.1 g, which allowed daily food intake to be
calculated. Feeding studies were started on the 14th day
after surgery and were allowed an interval of three
overnights in between studies for animal recovery from
eventual study distress. All animals had ad libitum access to
standard rat chow, except for the pair-fed group that was
fed daily with the same amount eaten by animals submitted
to gastric banding, except in the two feeding studies when
they were fed ad libitum.
Nighttime feeding study: This animal study was carried in
non-fasted rats starting out 1 h before the onset of dark phase
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(6:00 P.M.); food intake was measured at 1 h before dark and
1, 2, 4, 8, 12 and 24 h after dark (7:00 P.M.). Fast and refeed
study: Animals were fasted for 24 h before the study and refed
in the early light phase with a pre-weighed amount of regular
rat chow; food intake was measured 1, 2, 4, 8, and 24 h after
refeeding by weighing the remaining food in the hopper.
Epididymal White Adipose Tissue Weight
At the end of the experiment, 21 days after surgery, 24 h
fasted rats were killed by decapitation, and epididymal white
adipose tissue pads were removed and weighed using a scale
recording to nearest 0.001 g (Kern 440, Version 3.2).
Hormone Measurements
At time of killing, trunk blood was collected into chilled
lithium heparin tubes containing a Kallikrein inhibitor,
aprotinin (0.2 ml; Trasylol, Bayer, Portugal). Tubes were
kept on melting ice until centrifuging at 3,000 rpm for 8 min
at 4°C, and plasma was separated and kept at −20° until
analysis. All samples were assayed in duplicate within one
assay after a single freeze-thaw cycle. Hormone levels were
analyzed by specific radioimmunoassays using commerc-
ially available kits for total ghrelin (GHRT-89HK, Linco
Research, St. Charles, Mo., USA), PYY (RMPYY-68HK,
Linco Research), GLP-1 (GLP1A-35HK, Linco Research),
insulin (RI-13K, Linco Research), and leptin (RL-83K,
Linco Research) according to the manufacturer’s instruc-
tions. Glucose was analyzed in trunk blood before centri-
fuging by the glucose oxidase method using a glucometer
(One Touch Ultra, Lifescan, Johnson and Johnson, Milipitas,
CA). Triglycerides were analyzed by colorimetric test
(VITROS Analyzer, Johnson & Johnson, UK).
Hypothalamic NPY Gene Expression
Brains were rapidly removed, after killing of the rats, and
the basal hypothalamus was carefully dissected and frozen
by immersion in liquid nitrogen. Samples were kept at
−80°C until RNA extraction. Total RNA was extracted
from frozen dissected hypothalami using Trizol Reagent
(Invitrogen, Carlsbad, CA). Reverse transcription was
carried out using optimized amounts (1 μg) of total RNA
with a SuperScript first-strand synthesis system for reverse
transcription–polymerase chain reaction (RT-PCR; Invitro-
gen) in a final volume of 20 μl. Semiquantitative RT-PCR
was used to measure NPY mRNA in the basal hypothal-
amus. First-strand cDNA species were PCR amplified using
the following primers, NPY, 5′-TGGACTGACCCTCGCT
CTAT-3′ and 5′-TGTCTCAGGGCTGGATCTCT-3′. Com-
plementary DNA was also generated for the housekeeping
gene β-actin using 5′-TGTCACCAACTGGGACGATA-3′
and 5′-TCTCAGCTGTGGTGGTGAAG-3′. For amplifica-
tion of cDNA, PCR was performed with 1 μl template
cDNA and 49 μl PCR mix. Optical density was calculated
for the NPY gene product and the results expressed as the
ratio of its density to that of the β-actin product.
Statistical Analysis
Analysis of variance was used for comparison of the means
between the groups with post hoc least square difference test
and Bonferroni correction to assess specific group compar-
isons where applicable. Calculations were made using the
SPSS statistical package for Windows version 14.0. Results
are shown as means±SEM, unless otherwise specified. A
p value <0.05 was considered to be statistically significant.
Results
Body Weight and Food Intake After Gastric Banding
Gastric banding of obese Zucker rats resulted in a
statistically significant decreases in body weight, in
cumulative body weight gain (59.6±13.3 g vs 92.0±4.1 g
for the control sham-operated rats; p=0.012; Fig. 1a and b)
and in food intake (446.2±38.8 g vs 571.4±17.2 g for
sham-operated rats; p=0.005; Fig. 2). Furthermore, the
cumulative body weight gain of gastric banded obese
Zucker rats was similar both to the one displayed by lean
Zucker rats (fa/+) and by the food-restricted sham-operated
obese rats pair-fed to the gastric banded animals (59.6±
13.3 g vs 67.7±2.3 g for the sham-operated pair-fed rats
and 66.4±2.0 g for lean controls).
Feeding Behavior: Nighttime and Fast
and Refeed Feeding Studies
Under resting conditions, the rat feeding pattern of lean and
obese controls was significantly different, as expected. The
lean group had a lower food intake in comparison to that of
obese animals of any other group (22.1±0.6 g vs 31.3±
1.7 g for gastric banded rats, 31.4±0.8 g for sham-operated,
32.4±0.7 g for sham-operated pair-fed; p<0.05), except
during peak feeding hours, i.e., in the first hour before and
after dark. The food-restricted pair-fed obese rats, in the
first peak feeding hour, showed higher food intake when
compared to food intake of the other groups of animals,
lean or obese (4.7±0.4 g vs 2.8±0.2 g for gastric banded
rats, 3.0±0.4 g for sham-operated, 2.9±0.3 g for lean
controls; p=0.032; Fig. 3a).
Obese rats submitted to bariatric surgery with gastric
banding when compared to sham-operated animals had a
different feeding behavior if refed after 24-h fasting. After
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refeeding, gastric banded obese rats showed statistically
significant decrease in food intake during the first 2 h (5.3±
0.9 g vs 8.6±0.6 g for sham-operated, 6.7±0.5 g for sham-
operated pair-fed; p<0.05) and from 8 to 24 h after
refeeding in comparison with sham-operated obese rats
(26.8±3.6 g vs 33.9±1.2 g for sham-operated, 32.4±0.7 g
for sham-operated pair-fed; p<0.05). The feeding behavior
displayed by the obese rats submitted to banded gastro-
plasty, after a 24-h fast, was similar to that of lean rats
(Fig. 3b).
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Fig. 1 a Absolute body weight
of lean controls and obese
Zucker rats after gastric
banding, sham-operated fed ad
libitum and sham-operated
pair-fed to the gastric banded
animals. b Cumulative body
weight gain of lean controls and
obese Zucker rats after gastric
banding; sham operation fed ad
libitum and sham operation
pair-fed to the gastric banded
animals. Body weight gain of
obese Zucker rats was
significantly higher than the
other three groups of animals
that displayed similar body
weight gain (*p<0.05)
0
100
200
300
400
500
600
700
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21
Days after surgery
C
u
m
u
la
ti
v
e
 f
o
o
d
 i
n
ta
k
e
 (
g
ra
m
s
)
Gastric banded Sham fa/fa Sham fa/+
**
**
**
**
**
Fig. 2 Cumulative food intake
of lean controls, obese Zucker
rats gastric banded, and obese
Zucker rats sham-operated fed
ad libitum. Food intake of
sham-operated rats fed ad
libitum was significantly higher
when compared to the other
three groups of animals
(**p<0.01). Food intake of
sham-operated pair-fed animals
is not shown, as it was similar to
the gastric banded rats
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Body Composition
Fat mass, assessed by epididymal white adipose tissue (WAT)
weight per 100 g of body weight, was lower in the lean rats
( fa/+) than in obese Zucker rats ( fa/fa; 0.67±0.03 g vs
1.68±0.1 g for gastric banded, 1.69±0.1 g for sham-operated,
and 1.92±0.1 g for sham-operated pair-fed; p<0.001).
Epididymal WAT mass was higher in the sham-operated rats
pair-fed than in gastric banded and sham-operated rats fed ad
libitum. There was a statistically significant difference in
epididymal WAT between the gastric banded and pair-fed
obese animals ( p=0.036; Fig. 4).
Hormone Measurements
Fasting ghrelin levels were significantly higher in lean
Zucker rats ( fa/+) than in the obese rats ( fa/fa; 2,969.9±
150.9 g vs 963.2±54.3 g for sham-operated rats and
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Fig. 3 a Twenty-four-hour
cumulative food intake starting
at peak feeding times, 1 h before
dark phase, of lean controls and
obese Zucker rats after gastric
banding, sham-operation fed ad
libitum and sham-operated
pair-fed to the gastric banded
animals (*p<0.05).
b Cumulative food intake after
24 h fast of lean controls and
obese Zucker rats after gastric
banding, sham operation fed ad
libitum and sham-operated
pair-fed to the gastric banded
animals (*p<0.05)
0,000
0,500
1,000
1,500
2,000
2,500
E
p
id
id
y
m
a
l 
W
A
T
 w
e
ig
h
t/
 1
0
0
 g
Gastric banded Sham fa/fa Sham PF fa/fa Sham fa/+
*
***
Fig. 4 Epididymal WAT
weight/100 g of body weight
of lean controls and obese
Zucker rats after gastric
banding, sham operation fed ad
libitum, and sham-operated
pair-fed to the gastric banded
animals 21 days after surgery
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1,116.9±103.3 g for gastric banded rats; p<0.001). Food-
restricted obese rats pair-fed to the gastric banded presented
a significant increase in fasting ghrelin levels towards
similar values to those displayed by lean rats. This was not
observed in obese animals after gastric banding in spite of
similar decrease in food intake and body weight gain
(3,079.5±221.6 g for pair-fed animals vs 1,116.9±103.3 g
for gastric banded rats; p<0.001 and 2,969.9±150.9 g for
lean rats; p value not significant; Fig. 5). Fasting levels of
PYY and GLP-1 were similar in the four groups of animals
(Table 1).
Lean Zucker rats ( fa/+) had significantly lower fasting
triglycerides, glucose, insulin, and leptin plasma levels
when compared to all groups of obese Zucker rats ( fa/fa),
gastric banded, sham-operated fed ad libitum, and sham-
operated pair-fed to the gastric banded ( p<0.001). Fur-
thermore, fasting triglycerides, insulin, and leptin plasma
levels were higher in food-restricted sham-operated pair-fed
animals than in gastric banded and sham-operated rats fed
ad libitum, although it failed to reach statistical significance
(Table 1).
NPY mRNA Expression in the Basal Hypothalamus
NPY/β-actin mRNA expression in the basal hypothalamus
of obese ( fa/fa) Zucker rats submitted to gastric banding
was lower than the one presented by sham-operated obese
animals (0.58±0.04 vs 0.61±0.02 for the sham-operated
rats), but there was not a statistically significant difference
(Fig. 6).
Discussion
We document here the metabolic and endocrine changes
that occur in a rodent model of obesity after gastric
banding. For that, we have used obese Zucker rats ( fa/fa)
submitted to bariatric surgery with gastric banding and
compared them to two groups of sham-operated animals,
one fed ad libitum and another food-restricted to the same
amount eaten by the gastric banded animals (pair-fed). Rat
gastric banding was herein performed according to a
surgical procedure that we have recently introduced and
applied to lean Wistar rats [27, 28].
We have confirmed that obese animals had increased
food intake, body weight gain, and fat mass as assessed by
epididymal WATweight when compared to lean rats ( fa/+).
Moreover, common features of the metabolic syndrome,
such as fasting triglycerides, glucose, and insulin, were
increased in the obese rats; as expected, leptin plasma
levels, indicating increased adiposity and leptin resistance,
were also elevated.
After bariatric surgery with gastric banding, the obese
Zucker rat showed a decrease in food intake and body
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Fig. 5 Fasting plasma ghrelin
levels of lean controls and obese
Zucker rats after gastric
banding, sham operation fed ad
libitum, and sham-operated
pair-fed to the gastric banded
animals 21 days after the
surgeries
Table 1 Gastrointestinal hormones and metabolic parameters in obese Zucker rats after gastric banding, sham-operated fed ad libitum, sham-
operated pair-fed, and lean controls
Gastric banded Sham ( fa/fa) Sham PF ( fa/fa) Sham ( fa/+) Sig.
Glucose (mg/dl) 144.9±3.5 131.0±6.9 132.7±6.2 100.4±5.2 p<0.001
Triglycerides (mg/dl) 352.4±47.8 476.0±0.17 578.0±44.3 43.5±4.5 p<0.001
Insulin (ng/ml) 7.2±0.7 7.8±0.8 8.0±0.6 0.8±0.1 p<0.001
Leptin (ng/ml) 38.2±2.4 42.4±2.7 46.0±1.8 2.5±0.2 p<0.001
Ghrelin (pg/ml) 1,116.9±103.2 963.2±54.3 3,079.5±221.6 2,969.9±150.9 p<0.001
GLP-1 (pmol/l) 82.9±1.4 83.2±1.9 80.4±3.9 84.9±1.0 NS
PYY (pg/ml) 72.2±16.4 82.7±26.3 67.0±17.5 29.3±8.1 NS
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weight gain to levels that were similar to the ones observed
in their lean counterparts, while also restoring a normal
feeding behavior after fasting.
The obese Zucker rats ( fa/fa) had significantly lower
levels of circulating ghrelin than the lean controls ( fa/+).
Food-restricted rats pair-fed to the gastric banded ones had
fasting ghrelin levels significantly higher than obese rats fed
ad libitum, a feature that was not observed in gastric banded
rats, in spite of similar decrease in food intake and weight
loss. Ghrelin is a 28-amino-acid peptide hormone produced
mainly in the stomach fundus and is the most potent appetite-
stimulating hormone coming from the gastrointestinal tract
[29]. Ghrelin is generally up-regulated under conditions of
negative energy balance and down-regulated in the setting
of positive energy balance; fasting serum ghrelin levels are
usually low in obese subjects compared with lean individ-
uals [30], and fasting plasma levels rise with diet induced
weight loss [14, 31]. Ghrelin was shown to increase food
intake dose-dependently in lean and obese Zucker rats [32].
Although there is an inverse correlation between ghrelin
levels and body weight and ghrelin plasma levels are lower
in the obese fatty Zucker rats when compared to the lean
ones [33, 34], obese Zucker rats have an increased
sensitivity to ghrelin feeding effects caused by enhanced
expression of ghrelin receptor in the hypothalamus [32].
Hence, ghrelin is thought to have a role in the development
of obesity of Zucker rats in the absence of leptin signaling,
as leptin is able to inhibit the effects of ghrelin by
diminishing the expression of its receptor [35–37].
Cummings et al. [14] were the first to report failure to
increase ghrelin levels in weight loss attained after gastric
bypass in humans. Since this first report, other investigators
have found that the effect of bariatric surgery on ghrelin
levels was highly variable. Fasting ghrelin levels have been
found to increase 2 years after vertical banded gastroplasty
[38] and in patients who attained 20% body mass index
(BMI) loss [39]. Likewise, in obese patients 6 months [9,
16, 18, 19, 40, 41], 12 months [17, 19, 40], and 24 months
[38, 40] after being submitted to adjustable gastric banding,
fasting ghrelin levels have been shown to increase,
similarly to diet induced weight loss, although the increase
in ghrelin levels was greater after surgery than after diet-
induced weight loss, and this could be explained by the
higher amount of weight loss achieved with surgery.
Furthermore, postoperative ghrelin levels were also reported
as not being different from those of non-operated BMI-
matched patients [9]. However, some controversy remains,
as other authors have found that ghrelin levels remain stable
6 months after surgery [17, 42] or return to near baseline
levels from 24 to 36 months after surgery [19].
In our investigation, fasting levels of PYY and GLP-1
were not significantly different between the four groups of
animals. PYY (3-36) and GLP-1 (7-36) are satiety signals
released by the endocrine L cells of the gastrointestinal tract
after meals that have been shown to reduce food intake and
body weight gain in obese Zucker rats [43–45]. In humans,
fasting and post-prandial plasma levels of PYY increase
progressively 6 and 12 months after vertical banded
gastroplasty surgery [46]. Some authors have found that
the PYY area under the curve after a test meal was also
superior in obese patients submitted to gastric banding when
compared weight-matched obese controls [15], although in
another similar study, this was not found to be the case
[47]. Six months after vertical banded gastroplasty, fasting
plasma GLP-1 concentrations did not change significantly,
but the area under the curve during an oral glucose
tolerance test strikingly increased [48]. However, in another
study involving patients submitted to gastric banding, GLP-1
levels after a test meal were similar to body-weight-matched
obese controls [15]. It is pertinent to add that fasting levels
of PYY and GLP-1 are generally low, and changes in these
anorexigenic signals occur in the post-prandial period.
We found that fasting NPY mRNA expression in the
basal hypothalamus of gastric banded obese animals, in
spite of decreased food intake and body weight, was lower
than the observed in sham-operated rats, although this
difference did not reach statistical significance. NPY is
expressed in abundance in the arcuate nucleus (ARC) and
paraventricular nucleus of the basal hypothalamus; it is the
most potent stimulator of food intake and therefore plays a
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major role in regulation of food intake [49]. NPY
concentrations in the hypothalamus increase in food-
deprived animals and are normalized by food ingestion
[50, 51]. In the obese Zucker rat ( fa/fa), NPY secretion is
increased and does not decrease significantly with food
ingestion, explaining the continuous stimulation of feeding
behavior observed in these animals [52]. NPY mRNA
expression in the ARC is generally in good agreement with
peptide content [53], being increased in fed obese Zucker
rats ( fa/fa) when compared to lean Zucker rats and further
increased after fasting [54].
Studies have shown that after gastric banding, patients
experience increased fasting and post-prandial satiety levels
[7] and decreased hunger scores [8–10]. Variations in
gastrointestinal hormone levels have been proposed as a
contributing mechanism for the weight reduction observed
after bariatric surgery, and several clinical groups have
investigated the effect of bariatric procedures on ghrelin,
PYY, and GLP-1 levels. Overall, most of the available
human data have so far provided conflicting results. This
could be a consequence of underpowered studies, as most are
cross-sectional, making it difficult to isolate the role of
surgery from that of weight loss, and longitudinal studies
include small numbers of patients with non-homogeneous
populations, which are not readily comparable between each
other because of different intervals after surgery, variable
BMI or excess weight loss, and minor differences in surgical
techniques. Thus, information regarding endocrine mecha-
nism underlying obesity surgery remains to be substantiated.
There are numerous methodological and ethical limitations
inherent in performing detailed physiologic experiments in
humans. Animal models provide an invaluable tool for the
study of appetite regulation pathways and avoid the
heterogeneity inherent to human studies.
In our rat model of bariatric surgery with gastric
banding, we have documented that in the course of 21 days
after operation, which is comparable to that observed over
2 years in human patients [55], animals reduced their food
intake and body weight in comparison to obese controls
while also restored normal feeding behavior after fasting.
Furthermore, fasting ghrelin levels did not increase when
compared to sham-operated animals fed ad libitum and
were significantly lower than the levels presented by
weight-matched food-restricted (pair-fed) rats. In addition,
gastric banded rats were leaner than weight-matched pair-
fed sham-operated animals as expressed by lower plasma
leptin levels and by a significantly lower epididymal WAT
weight, both indicators of adiposity. Moreover, there was
also a non-significant decrease in fasting triglycerides and
insulin levels of gastric banded rats when compared to
sham-operated animals fed ad libitum and food-restricted
sham-operated rats. Altogether, these results suggest that
the metabolic and endocrine changes after gastric banding
do not depend solely on food restriction and weight loss
and indicate that the mechanisms of weight loss in these
two groups of rats may not be similar.
In conclusion, these data provide evidence that in spite
of ongoing leptin resistance, gastric banding decreases food
intake and body weight gain in obese Zucker rats to levels
that are similar to their lean counterparts while also
restoring normal feeding behavior after fasting. Further-
more, gastric banding leads to an improvement in metabolic
features and prevents the increase in this counter regulatory
orexigenic signals that occur during caloric deprivation,
such as increase in fasting ghrelin plasma levels and NPY
expression in the basal hypothalamus. Taken together, these
changes suggest that gastric banding decreases the orexi-
genic signals to the brain centers, regulating food intake
that normally occur after diet-induced weight loss.
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